In this study, we have demonstrated for the first time that guanosine possesses in vitro antiplatelet activity (secretion, spreading, adhesion and aggregation) and inhibition of platelet inflammatory mediator of atherosclerosis (sCD40L). Here, CD40LG is linked to atherosclerosis.